TuHURA BIOSCIENCES, INC./NV Debt Issuance Costs, Net
TuHURA BIOSCIENCES, INC./NV (HURA) had Debt Issuance Costs, Net of $7.30 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Debt › Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net › Debt Issuance Costs, Net
us-gaap:DeferredFinanceCostsNet · last filed 2026-08-14
- 2026-06-30: Debt Issuance Costs, Net $7.30M.
- 2025-12-31: Debt Issuance Costs, Net $0.00.
- 2020-06-30: Debt Issuance Costs, Net $84.94K.
| Period end | Debt Issuance Costs, Net |
|---|---|
| 2026-06-30 | $7.30M 10-Q · filed 2026-08-14 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-14 |
| 2020-06-30 | $84.94K 10-K · filed 2020-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |